These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20954365)

  • 1. [Experimental inhalation therapy with nebulized tiotropium in COPD patients unable to use the Handihaler].
    Yoshizawa T; Iwashiro M; Yoshizawa A
    Nihon Kokyuki Gakkai Zasshi; 2010 Sep; 48(9):649-53. PubMed ID: 20954365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiotropium Respimat inhaler and the risk of death in COPD.
    Wise RA; Anzueto A; Cotton D; Dahl R; Devins T; Disse B; Dusser D; Joseph E; Kattenbeck S; Koenen-Bergmann M; Pledger G; Calverley P;
    N Engl J Med; 2013 Oct; 369(16):1491-501. PubMed ID: 23992515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    van Noord JA; Cornelissen PJ; Aumann JL; Platz J; Mueller A; Fogarty C
    Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
    Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium HandiHaler in the treatment of COPD: a safety review.
    Kesten S; Celli B; Decramer M; Leimer I; Tashkin D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():397-409. PubMed ID: 20037679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium 5microg via Respimat and 18microg via HandiHaler; efficacy and safety in Japanese COPD patients.
    Ichinose M; Fujimoto T; Fukuchi Y
    Respir Med; 2010 Feb; 104(2):228-36. PubMed ID: 19969446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
    Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
    Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
    Tashkin DP; Hanania NA; McGinty J; Denis-Mize K; Chaudry I
    Adv Ther; 2009 Nov; 26(11):1024-34. PubMed ID: 19953349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tiotropium. A new anti-cholinergic agent for treatment of chronic obstructive pulmonary disease].
    Pedersen ST; Lange P
    Ugeskr Laeger; 2003 May; 165(22):2279-83. PubMed ID: 12830753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium: a new, long-acting agent for the management of COPD--a clinical review.
    Crutchfield D
    Director; 2004; 12(3):160, 162-4. PubMed ID: 15323298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial].
    Stepanian IE; Khmel'kova NG; Belin-Atarac B
    Ter Arkh; 2010; 82(10):46-51. PubMed ID: 21341464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.
    Tashkin DP; Donohue JF; Mahler DA; Huang H; Goodwin E; Schaefer K; Hanrahan JP; Andrews WT
    Respir Med; 2009 Apr; 103(4):516-24. PubMed ID: 19208459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease.
    Covelli H; Bhattacharya S; Cassino C; Conoscenti C; Kesten S
    Pharmacotherapy; 2005 Dec; 25(12):1708-18. PubMed ID: 16305289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD.
    Verhamme KM; Afonso A; Romio S; Stricker BC; Brusselle GG; Sturkenboom MC
    Eur Respir J; 2013 Sep; 42(3):606-15. PubMed ID: 23520322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.
    Wise R; Calverley PM; Dahl R; Dusser D; Metzdorf N; Müller A; Fowler A; Anzueto A
    NPJ Prim Care Respir Med; 2015 Nov; 25():15067. PubMed ID: 26540491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.
    Keating GM
    Drugs; 2014 Oct; 74(15):1801-16. PubMed ID: 25300412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease].
    Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD.
    Verhamme KM; Afonso AS; van Noord C; Haag MD; Koudstaal PJ; Brusselle GG; Sturkenboom MC
    Pulm Pharmacol Ther; 2012 Feb; 25(1):19-26. PubMed ID: 22051450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.